Pharmacokinetics and pharmacodynamics of stereoisomeric drugs with particular reference to bioequivalence determination

Journal of Veterinary Pharmacology and Therapeutics

Volumn 35, Issue SUPPL. 1, 2012, Pages 17-29

  Lees, P ^a   Hunter, R P ^b   Reeves, P T ^c   Toutain, P L ^d  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b ELANCO ANIMAL HEALTH   (United States)

^c Australian Pesticides and Veterinary Medicines Authority   (Australia)

^d UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; AMINO ACID; BENZIMIDAZOLE; BETA LACTAM ANTIBIOTIC; BUPIVACAINE; CARBOHYDRATE; CARBON; CARPROFEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DOBUTAMINE; EXCIPIENT; FENBENDAZOLE; FLURBIPROFEN; HYDROXYCHLOROQUINE; KETOPROFEN; NADOLOL; NITROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OROSOMUCOID; OXFENDAZOLE; PHOSPHORUS; PROPAFENONE; PROPRANOLOL; SERINE; SULFUR; THALIDOMIDE;

ANALYTIC METHOD; BILIARY EXCRETION; BIOCHEMISTRY; BIOEQUIVALENCE; CHIRALITY; DECISION TREE; DRUG ABSORPTION; DRUG ELIMINATION; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG RESPONSE; ENANTIOMER; ENZYME INHIBITION; GENETIC POLYMORPHISM; ISOMER; MOLECULAR MECHANICS; NOMENCLATURE; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RACEMIC MIXTURE; REVIEW; STEREOCHEMISTRY; STEREOISOMERISM; SYNTHESIS;

ANIMALS; MOLECULAR STRUCTURE; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP; THERAPEUTIC EQUIVALENCY; VETERINARY DRUGS;

EID: 84858167694     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2012.01367.x     Document Type: Review

References (60)

1. Ariens, E.J. (1986) Chirality in bioactive agents and its pitfalls. Trends in Pharmaceutical Sciences, 7, 200-205.
2. Barrett, J.S., Batra, V., Chow, A., Cook, J., Gould, A.L., Heller, A.H., Lo, M.W., Patterson, S.D., Smith, B.P., Stritar, J.A., Vega, J.M. & Zariffa, N. (2000) PhRMA perspective on population and individual bioequivalence. Journal of Clinical Pharmacology, 40, 561-572.
3. Berry, B.W. & Jamali, F. (1991) Presystemic and systemic chiral inversion of R(-) fenoprofen in the rat. Journal of Pharmacology &l Experimental Therapeutics, 25B, 695-701.
4. Brayden, D.J., Oudet, E.M. & Baird, A.W. (2010) Drug delivery systems in domestic animal species. In Comparative and Veterinary Pharmacology. Eds Cunningham, F.M., Elliott, J. & Lees, P., pp. 79-112. Springer-Verlag, Berlin, Germany.
5. Brocks, D.R. (2006) Drug disposition in three dimensions: an update on stereoselectivity in pharmacokinetics. Biopharmaceutics & Drug Disposition, 27, 387-406.
6. Brocks, D.R., Skeith, K.J., Johnston, C., Emamibafrani, J., Davis, P., Russell, A.S. & Jamali, F. (1994) Hematologic disposition of hydroxychloroquine enantiomers. Journal of Clinical Pharmacology, 34, 1088-1097.
7. Cahn, R.S., Ingold, C.K. & Prelog, V. (1956) The specification of asymmetric configuration in organic chemistry. Experientia, 12, 81-124.
8. Caldwell, J., Hutt, A.J. & Fournel-Gigleux, S. (1988) The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences. Biochemical Pharmacology, 37, 105-114.
9. Campbell, D.B. (1990) Stereoselectivity in clinical pharmacokinetics and drug development. European Journal of Drug Metabolism and Pharmacokinetics, 15, 109-125.
10. Day, R.O., Williams, K.M., Graham, G.G., Lee, E.J., Knihinicki, R.D. & Champion, G.D. (1988) Stereoselective disposition of ibuprofen enantiomers in synovial fluid. Clinical Pharmacology and Therapeutics, 43, 480-487.
11. Delatour, P., Benoit, E., Caude, M. & Tambutu, A. (1990a) Species differences in the generation of the chiral sulphoxide metabolite of albendazole in sheep and rats. Chirality, 2, 156-160.
12. Delatour, P., Benoit, E., Garnier, F. & Besse, S. (1990b) Chirality of the sulphoxide metabolites of fenbendazole and albendazole in sheep. Journal of Veterinary Pharmacology and Therapeutics, 13, 361-366.
13. Delatour, P., Benoit, E., Besse, S. & Boukraa, A. (1991a) Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats. Xenobiotica, 21, 217-221.
14. Delatour, P., Garnier, E., Benoit, E. & Caude, I. (1991b) Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle. Research in Veterinary Science, 50, 134-138.
15. Delatour, P., Benoit, E., Besse, S. & Soraci, A. (1994) Asymetrie moléculaire et pharmacologie compaŕee. Revue Medécine Vétérinarie, 145, 551-561.
16. EMA (2010) Draft Guideline on the conduct of bioequivalence studies for veterinary medicinal products. EMEA/CVMP/016/00-Rev. 2-Consultation.
17. Evans, A.M. (1992) Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs. European Journal of Clinical Pharmacology, 42, 237-256.
18. Gould, A.L. (2000) A practical approach for evaluating population and individual bioequivalence. Statistics in Medicine, 19, 2721-2740.
19. Heard, C.M. & Brain, K.R. (2010) Does solute stereochemistry influence percutaneous penetration? Chirality, 7, 305-309.
20. Hooper, W.D. (1993) Are enantioselective assay methods necessary for comparative bioavailability studies on racemic drugs? Proceedings of Western Pharmacology Society, 36, 167-171.
21. Hooper, W.D., Dickinson, R.G. & Gal, J. (1992) Enantioselective versus non-enantioselective assays in comparative bioavailability studies with racemic drugs. Biopharmaceutics & Drug Disposition, 13, 383-387.
22. Ilett, K.F., Tee, L.G., Reeves, P.T. & Minchin, R.F. (1990) Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacology and Therapeutics, 46, 67-93.
23. Jamali, F. (1992) Stereochemistry and bioequivalence. Journal of Clinical Pharmacology, 32, 930-934.
24. Jamali, F., Collins, D. S., Berry, B. W., Molder, S., Cheung, R., McColl, K. & Cheung, H (1991). Biopharmacology Drug Disposition, 12, 435-445.
25. Janjikhel, R.K. & Adeyeye, C.M. (1999) Dissolution of ibuprofen enantiomers from coprecipitates and suspensions containing chiral excipients. Pharmaceutical Development & Technology, 4, 9-17.
26. Karim, A. (1996) Enantioselective assays in comparative bioavailability studies of racemic drug formulations: nice to know or need to know. Journal of Clinical Pharmacology, 36, 490-499.
27. King, J.N., Mauron, C., LeGoff, C. & Hauffe, S. (1994) Bidirectional chiral inversion of the enantiomers of the non-steroidal anti-inflammatory drug oxindanac in dogs. Chirality, 6, 460-466.
28. Koytchev, R., Alken, R.G., Mayer, O., Bohm, R., Ellrich, A. & Waldnerkolblin, R.G. (1995) Bioequivalence studies of two oral propafenone preparations. Arzneimittel Forschung, 45, 542-545.
29. Landoni, M.F., Soraci, A.L., Delatour, A. & Lees, P. (1997) Enantioselective behaviour of drugs used in domestic animals: a review. Journal of Veterinary Pharmacology and Therapeutics, 20, 1-16.
30. Lees, P., Landoni, M.F., Giraudel, J. & Toutain, P.L. (2004) Pharmacodynamics and pharmacokinetics of nonsteroidal anti-inflammatory drugs in species of veterinary interest. Journal of Veterinary Pharmacology & Therapeutics, 27, 479-490.
31. Lötsch, J., Geisslinger, G., Mohammadian, P., Brune, K. & Kobal, G. (1995) Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects. British Journal of Clinical Pharmacology, 40, 339-346.
32. Marzo, A. (1993) How incoming guidelines on chiral drugs could impact on the international scenary of drug development. Bollettino Chimico Farmaceutico, 132, 267-271.
33. Mehvar, R. (1994) Input rate-dependent stereoselective pharmacokinetics: effect of pulsatile oral input. Chirality, 6, 185-195.
34. Mehvar, R. & Jamali, F. (1997) Bioequivalence of chiral drugs: stereospecific versus non-stereospecific methods. Clinical Pharmacokinetics, 33, 122-141.
35. Midha, K.K., Hubbard, J.W., McKay, G., Rawson, M. & Schwede, R. (1995) Stereoselectivity in bioequivalence studies of nortriptyline. European Journal of Pharmaceutical Sciences, 84, 1265-1266.
36. Midha, K.K., Hubbard, J.W., Rawson, M.J. & Schwede, R. (1996) The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: a drug with a very long half-life. European Journal of Pharmaceutical Sciences, 4, 283-292.
37. Midha, K., McKay, G., Rawson, M.J. & Hubbard, J.W. (1998) The impact of stereoisomerism in bioequivalence studies. Journal of Pharmaceutical Sciences, 87, 797-802.
38. Najib, N.M., Salem, I., Hasan, R. & Idkaidek, N.M. (2009) Effect of truncated AUC method on drug bioequivalence in humans. Journal of Bioequivalence & Bioavailability, 1, 112-114.
39. Nation, R.L. & Sanson, L.N. (1994) Bioequivalence requirements for generic products. Pharmacology & Therapeutics, 62, 41-55.
40. Nerurkar, S.G., Dighe, S.V. & Williams, R.L. (1992) Bioequivalence of racemic drugs. Journal of Clinical Pharmacology, 32, 935-943.
41. Nerurkar, J., Beach, J.W., Park, M.O. & Jun, H.W. (2005) Solubility of (±)-ibuprofen and S(+)-ibuprofen in the presence of cosolvents and cyclodextrins. Pharmaceutical Development & Technology, 10, 413-421.
42. Nitchuk, W.M. (1992) Regulatory requirements for generic chiral drugs. Journal of Clinical Pharmacology, 32, 953-954.
43. Priymenko, N., Garnier, F., Ferre, J.P., Delatour, P. & Toutain, P.L. (1998) Enantioselectivity of the enterohepatic recycling of carprofen in the dog. Drug Metabolism & Disposition, 26, 170-176.
44. Priymenko, N., Koritz, G.D., Ferre, J.P., Laroute, M.F. & Toutain, P.L. (2004) Influence of feeding and analytical method on the bioequivalence of a racemic drug undergoing enantioselective enterohepatic recycling. Journal of Pharmaceutical Sciences, 93, 590-600.
45. Qureshi, S., Caille, G., Lacasse, Y. & McGilveray, I. (1994) Pharmacokinetics of two enteric-coated ketoprofen products in humans with or without coadministration of omeprazole and comparison with dissolution findings. Pharmaceutical Research, 11, 1669-1672.
46. Simonyi, M., Gal, J. & Testa, B. (1989) Signs of the times: the need for a stereochemically informative generic name system. Trends in Pharmacological Sciences, 10, 349-354.
47. Soraci, A.L., Benoit, E., Jaussaud, P., Lees, P. & Delatour, P. (1995) Enantioselective glucuronidation and subsequent biliary excretion of carprofen in horses. American Journal of Veterinary Research, 56, 358-361.
48. Srinivas, N.R. (2004) Role of stereoselective assays in bioequivalence studies of racemic drugs: have we reached a consensus? The Journal of Clinical Pharmacology, 44, 115-119.
49. Srinivas, N.R., Barr, W.H., Shyu, W.C., Mohandoss, E., Chow, S., Staggers, J., Balan, G., Belas, F.J., Blair, I.A. & Barbhaiya, R.H. (1996) Bioequivalence of two tablet formulations of nadolol using single and multiple dose data:assessment using stereospecific and nonstereospecific assays. Journal of Pharmaceutical Sciences, 85, 299-303.
50. Suedee, R., Srichana, T., Chotivatesin, R. & Martin, G.P. (2002) Stereoselective release behaviors of imprinted bead matrices. Drug Development and Industrial Pharmacy, 28, 545-554.
51. Tamai, I., Ling, H.Y., Timbul, S.M. & Nishikido, T.A. (1988) Stereospecific absorption and degradation of cephalexin. Journal of Pharmacy and Pharmacology, 40, 320-324.
52. Tanaka, Y., Shimomura, Y., Hirota, T., Nozaki, A., Ebata, M., Takasaki, W., Sigehara, E., Hayashi, R. & Caldwell, J. (1992) Formation of glycine conjugate and (-)- and (+)-enantiomers from (+)-(S)-2-phenylpropionic acid suggesting the formation of the CoA thioester intermediate in dogs. Chirality, 4, 342-348.
53. Testa, B., Carrup, P.A. & Gal, J. (1993) The so called 'interconversion' of stereoisomeric drugs: an attempt at clarification. Chirality, 5, 105-111.
54. Ticku, M.K., Rastogi, S.K. & Thyagarajan, R. (1985) Separate sites of action of optical isomers of 1-methyl-5-phenyl-5-propylbarbituric acid with opposite pharmacological activities at the GABA receptor complex. European Journal of Pharmacology, 112, 1-9.
55. Toutain, P.L. & Lees, P. (2004) Integration and modelling of pharmacokinetic and pharmacodynamic data to optimize dosage regimens in veterinary medicine. Journal of Veterinary Pharmacology & Therapeutics, 27, 467-477.
56. Tucker, G.I. & Lennard, M.S. (1990) Enantiomer specific pharmacokinetics. Pharmacology and Therapeutics, 45, 309-329.
57. Van't Hoff, J.H. (1898) The Arrangement of Atoms in Space. Longmans Green, London, UK.
58. Wang, Y., Cao, J., Wang, X. & Zeng, S. (2010) Stereoselective transport and uptake of propranolol across human intestinal Caco-2 cell monolayers. Chirality, 22, 361-368.
59. Wechter, W.J. (1992) From controversy to resolution: bioequivalence of racemic drugs - A. bioequivalency and analytical aspects of stereochemistry. Journal of Clinical Pharmacology, 32, 915-916.
60. Williams, K., Day, R., Knihinicki, R. & Duffield, A.P. (1986) The stereoselective uptake of ibuprofen enantiomers into adipose tissue. Biochemical Pharmacology, 35, 3403-3405.